Guangzhou Kingmed Diagnostics Group Co Ltd (SHG:603882) — Market Cap & Net Worth
Market Cap & Net Worth: Guangzhou Kingmed Diagnostics Group Co Ltd (603882)
Guangzhou Kingmed Diagnostics Group Co Ltd (SHG:603882) has a market capitalization of $1.90 Billion (CN¥12.99 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #6327 globally and #1259 in its home market, demonstrating a 2.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangzhou Kingmed Diagnostics Group Co Ltd's stock price CN¥28.03 by its total outstanding shares 463258275 (463.26 Million). See Guangzhou Kingmed Diagnostics Group Co L (603882) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Guangzhou Kingmed Diagnostics Group Co Ltd Market Cap History: 2017 to 2026
Guangzhou Kingmed Diagnostics Group Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $2.04 Billion to $1.90 Billion (12.91% CAGR).
Guangzhou Kingmed Diagnostics Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangzhou Kingmed Diagnostics Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.32x
Guangzhou Kingmed Diagnostics Group Co Ltd's market cap is 0.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.04 Billion | $3.79 Billion | $188.51 Million | 0.54x | 10.82x |
| 2018 | $1.44 Billion | $4.53 Billion | $233.32 Million | 0.32x | 6.18x |
| 2019 | $3.32 Billion | $5.27 Billion | $402.33 Million | 0.63x | 8.26x |
| 2020 | $8.33 Billion | $8.24 Billion | $1.51 Billion | 1.01x | 5.51x |
| 2021 | $7.25 Billion | $11.94 Billion | $2.22 Billion | 0.61x | 3.27x |
| 2022 | $5.17 Billion | $15.48 Billion | $2.75 Billion | 0.33x | 1.88x |
| 2023 | $4.24 Billion | $8.54 Billion | $643.38 Million | 0.50x | 6.59x |
| 2024 | $1.87 Billion | $7.19 Billion | -$381.24 Million | 0.26x | N/A |
| 2025 | $1.92 Billion | $6.03 Billion | -$173.24 Million | 0.32x | N/A |
Competitor Companies of 603882 by Market Capitalization
Companies near Guangzhou Kingmed Diagnostics Group Co Ltd in the global market cap rankings as of August 7, 2026.
Key companies related to Guangzhou Kingmed Diagnostics Group Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $217.92 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #166 globally with a market cap of $141.26 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #517 globally with a market cap of $51.65 Billion USD ( CN¥352.94 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $217.92 Billion | $580.02 |
| #166 | Danaher Corporation | NYSE:DHR | $141.26 Billion | $199.98 |
| #517 | WuXi AppTec Co Ltd | SHG:603259 | $51.65 Billion | CN¥142.70 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $590.00 |
Guangzhou Kingmed Diagnostics Group Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Guangzhou Kingmed Diagnostics Group Co Ltd's market cap moved from $2.04 Billion to $ 1.90 Billion, with a yearly change of 12.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.90 Billion | -1.16% |
| 2025 | CN¥1.92 Billion | +3.01% |
| 2024 | CN¥1.87 Billion | -56.00% |
| 2023 | CN¥4.24 Billion | -17.98% |
| 2022 | CN¥5.17 Billion | -28.70% |
| 2021 | CN¥7.25 Billion | -12.87% |
| 2020 | CN¥8.33 Billion | +150.52% |
| 2019 | CN¥3.32 Billion | +130.54% |
| 2018 | CN¥1.44 Billion | -29.33% |
| 2017 | CN¥2.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 7th, 2026 the market cap of Guangzhou Kingmed Diagnostics Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.90 Billion USD |
| MoneyControl | $1.90 Billion USD |
| MarketWatch | $1.90 Billion USD |
| marketcap.company | $1.90 Billion USD |
| Reuters | $1.90 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.